Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Alpha Teknova, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Alpha Teknova, Inc. price/book ratio for the quarter ending 2026-06-30 was 4.85, a 40.50% increase year-over-year.
  • Alpha Teknova, Inc. price/book ratio for the quarter ending 2026-03-31 was 2.36, a 33.07% decline year-over-year.
  • Alpha Teknova, Inc. price/book ratio for the quarter ending 2025-12-31 was 2.95, a 45.47% decline year-over-year.
  • Alpha Teknova, Inc. price/book ratio for the quarter ending 2025-09-30 was 4.55, a 54.02% increase year-over-year.
  • Alpha Teknova, Inc. price/book ratio for fiscal 2026 was 4.85.
  • Alpha Teknova, Inc. price/book ratio for fiscal 2025 was 2.95, a 45.47% decline from fiscal 2024.
  • Alpha Teknova, Inc. price/book ratio for fiscal 2024 was 5.41, a 220.28% increase from fiscal 2023.
  • Alpha Teknova, Inc. price/book ratio for fiscal 2023 was 1.69, a 6.21% increase from fiscal 2022.
Available history
2021-06-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-304.85$303.84M$62.6M
2026-03-312.36$153.33M$64.92M
2025-12-312.95$203M$68.78M
2025-09-304.55$330.78M$72.65M
2025-06-303.45$262.76M$76.06M
2025-03-313.53$277.34M$78.61M
2024-12-315.41$445.97M$82.39M
2024-09-302.96$257.99M$87.27M
2024-06-300.71$56.05M$78.93M
2024-03-311.3$108.18M$83.38M
2023-12-311.69$152.16M$90.04M
2023-09-301.14$113.63M$99.65M
2023-06-300.88$75.67M$86.21M
2023-03-310.91$83.44M$92.09M
2022-12-311.59$158.93M$99.89M
2022-09-300.84$93.96M$112M
2022-06-301.77$235.88M$133.47M
2022-03-312.8$387.27M$138.55M
2021-12-314.01$573.69M$143.2M
2021-09-304.77$697.22M$146.23M
2021-06-304.46$664.72M$149.04M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-304.85$303.84M$62.6M
2025-12-312.95$203M$68.78M
2024-12-315.41$445.97M$82.39M
2023-12-311.69$152.16M$90.04M
2022-12-311.59$158.93M$99.89M
2021-12-314.01$573.69M$143.2M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92